Hims Hers Health Inc (NYSE:HIMS) — Market Cap & Net Worth
Market Cap & Net Worth: Hims Hers Health Inc (HIMS)
Hims Hers Health Inc (NYSE:HIMS) has a market capitalization of $3.71 Billion ($3.71 Billion) as of September 21, 2026. Listed on the NYSE stock exchange, this USA-based company holds position #4325 globally and #1487 in its home market, demonstrating a 2.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Hims Hers Health Inc's stock price $27.99 by its total outstanding shares 219270891 (219.27 Million). Also see Hims Hers Health Inc balance sheet assets for a full breakdown of the balance sheet.
Hims Hers Health Inc Market Cap History: 2019 to 2026
Hims Hers Health Inc's market capitalization history from 2019 to 2026. Data shows growth from $2.17 Billion to $6.14 Billion (16.13% CAGR). Also see HIMS cash generation efficiency for how efficiently the company converts equity into cash flow.
Index Memberships
Hims Hers Health Inc is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
S&P Midcap 400
MID
|
$3.43 Trillion | 0.20% | #329 of 401 |
Weight: Hims Hers Health Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Hims Hers Health Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Hims Hers Health Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check Hims Hers Health Inc (HIMS) stock price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
3.59x
Hims Hers Health Inc's market cap is 3.59 times its annual revenue
Latest Price to Earnings (P/E) Ratio
42.07x
Hims Hers Health Inc's market cap is 42.07 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2019 | $2.17 Billion | $82.56 Million | -$72.06 Million | 26.29x | N/A |
| 2020 | $3.20 Billion | $148.76 Million | -$18.11 Million | 21.52x | N/A |
| 2021 | $1.44 Billion | $271.88 Million | -$107.66 Million | 5.28x | N/A |
| 2022 | $1.41 Billion | $526.92 Million | -$65.68 Million | 2.67x | N/A |
| 2023 | $1.95 Billion | $872.00 Million | -$23.55 Million | 2.24x | N/A |
| 2024 | $5.30 Billion | $1.48 Billion | $126.04 Million | 3.59x | 42.07x |
Competitor Companies of HIMS by Market Capitalization
Companies near Hims Hers Health Inc in the global market cap rankings as of September 21, 2026. Review Hims Hers Health Inc tangible book value ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Hims Hers Health Inc by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #518 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #612 globally with a market cap of $44.92 Billion USD.
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #635 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #670 globally with a market cap of $40.99 Billion USD ( CN¥280.10 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #518 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #612 | GALDERMA GROUP AG | NYSE:GALDY | $44.92 Billion | $38.53 |
| #635 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €16.90 |
| #670 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $40.99 Billion | CN¥43.91 |
Hims Hers Health Inc Historical Marketcap From 2019 to 2026
Between 2019 and today, Hims Hers Health Inc's market cap moved from $2.17 Billion to $ 6.14 Billion, with a yearly change of 16.13%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $6.14 Billion | -13.80% |
| 2025 | $7.12 Billion | +34.28% |
| 2024 | $5.30 Billion | +171.69% |
| 2023 | $1.95 Billion | +38.85% |
| 2022 | $1.41 Billion | -2.14% |
| 2021 | $1.44 Billion | -55.14% |
| 2020 | $3.20 Billion | +47.47% |
| 2019 | $2.17 Billion | -- |
End of Day Market Cap According to Different Sources
On Sep 20th, 2026 the market cap of Hims Hers Health Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $3.71 Billion USD |
| MoneyControl | $3.71 Billion USD |
| MarketWatch | $3.71 Billion USD |
| marketcap.company | $3.71 Billion USD |
| Reuters | $3.71 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Hims Hers Health Inc
Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provi… Read more